NADOLOL

NADOLOL was reported 7587 times

NADOLOL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VAGINAL FLATULENCE 188 0.6205
1 FEMALE GENITAL TRACT FISTULA 198 0.1159
2 RADICULOPATHY 197 0.0747
3 CHRONIC SINUSITIS 265 0.0705
4 MACULAR DEGENERATION 831 0.0695
5 PROCTITIS 187 0.0667
6 VASCULAR ACCESS SITE PAIN 7 0.0583
7 HYPERPLASTIC CHOLECYSTOPATHY 7 0.0519
8 NONALCOHOLIC FATTY LIVER DISEASE 8 0.0408
9 PORTAL HYPERTENSIVE GASTROPATHY 16 0.0284
10 VARICES OESOPHAGEAL 76 0.0251
11 GASTRIC VARICES 10 0.0212
12 BLOOD URIC ACID DECREASED 10 0.0206
13 VAGINAL DISCHARGE 190 0.0188
14 CIRRHOSIS ALCOHOLIC 8 0.0175
15 AMMONIA ABNORMAL 7 0.0174
16 PARAESTHESIA ORAL 245 0.0170
17 OESOPHAGEAL VARICES HAEMORRHAGE 34 0.0156
18 HEPATORENAL FAILURE 9 0.0150
19 ORAL CANDIDIASIS 197 0.0149
20 HYPERTROPHY 8 0.0147
21 GASTRIC ANTRAL VASCULAR ECTASIA 7 0.0132
22 COLON ADENOMA 13 0.0132
23 CONVULSIVE THRESHOLD LOWERED 5 0.0127
24 CANDIDA TEST POSITIVE 5 0.0120
25 ELECTROCARDIOGRAM PR PROLONGATION 9 0.0118
26 BLOOD OSMOLARITY DECREASED 7 0.0112
27 BLEEDING VARICOSE VEIN 6 0.0111
28 BLOOD PRESSURE DIASTOLIC ABNORMAL 24 0.0094
29 HEPATIC ENCEPHALOPATHY 86 0.0092
30 AMMONIA INCREASED 47 0.0092
31 OPEN REDUCTION OF FRACTURE 10 0.0087
32 PROCEDURAL PAIN 230 0.0083
33 BLOOD ALBUMIN INCREASED 7 0.0079
34 CHORIORETINITIS 5 0.0078
35 FREQUENT BOWEL MOVEMENTS 209 0.0077
36 HYPOGLYCAEMIC SEIZURE 7 0.0077
37 SINUS ARREST 12 0.0076
38 LONG QT SYNDROME 18 0.0075
39 HEPATIC CIRRHOSIS 131 0.0070
40 HEMIANOPIA HOMONYMOUS 5 0.0068
41 PORTAL HYPERTENSION 21 0.0068
42 HEPATORENAL SYNDROME 11 0.0065
43 RIGHT VENTRICULAR DYSFUNCTION 7 0.0063
44 MYELOPATHY 12 0.0063
45 INSULIN-LIKE GROWTH FACTOR INCREASED 9 0.0063
46 BLOOD BILIRUBIN ABNORMAL 8 0.0062
47 AORTIC ARTERIOSCLEROSIS 16 0.0062
48 PORTAL VEIN THROMBOSIS 20 0.0062
49 ENTEROCOCCAL SEPSIS 5 0.0062
50 RECTAL HAEMORRHAGE 264 0.0061
51 PYURIA 6 0.0061
52 NEONATAL HYPOXIA 5 0.0060
53 HEPATIC HAEMORRHAGE 5 0.0058
54 WAIST CIRCUMFERENCE INCREASED 6 0.0058
55 COLITIS 203 0.0053
56 OESOPHAGEAL HAEMORRHAGE 7 0.0053
57 OLIGOHYDRAMNIOS 17 0.0051
58 INTRA-ABDOMINAL FLUID COLLECTION 9 0.0050
59 MESENTERIC VEIN THROMBOSIS 5 0.0050
60 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 6 0.0050
61 HYPOGLYCAEMIA NEONATAL 8 0.0049
62 BLOOD PRESSURE SYSTOLIC ABNORMAL 12 0.0049
63 COLITIS ULCERATIVE 208 0.0046
64 BRONCHIAL DISORDER 7 0.0045
65 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 6 0.0044
66 KLEBSIELLA SEPSIS 5 0.0044
67 HAEMATOCHEZIA 241 0.0044
68 HEAD TITUBATION 6 0.0044
69 HEPATOSPLENOMEGALY 11 0.0043
70 SPLENOMEGALY 49 0.0042
71 VENTRICULAR ARRHYTHMIA 15 0.0041
72 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 289 0.0041
73 EAR CONGESTION 11 0.0041
74 INFUSION RELATED REACTION 268 0.0040
75 HYPOGLYCAEMIC UNCONSCIOUSNESS 8 0.0040
76 SYSTEMIC CANDIDA 10 0.0040
77 BLOOD CHLORIDE DECREASED 10 0.0039
78 LIVER TRANSPLANT 14 0.0038
79 BLOOD CREATININE DECREASED 12 0.0038
80 HYPERACUSIS 14 0.0038
81 COLONIC POLYP 6 0.0036
82 ATYPICAL FEMUR FRACTURE 10 0.0035
83 DIABETES MELLITUS NON-INSULIN-DEPENDENT 5 0.0034
84 NODAL RHYTHM 5 0.0034
85 ORAL INTAKE REDUCED 8 0.0033
86 ASCITES 97 0.0033
87 PNEUMONIA KLEBSIELLA 6 0.0033
88 BLOOD PRESSURE DIASTOLIC DECREASED 24 0.0032
89 HYPOPHOSPHATAEMIA 24 0.0032
90 AUTOIMMUNE HAEMOLYTIC ANAEMIA 11 0.0032
91 TORSADE DE POINTES 25 0.0032
92 LIGAMENT SPRAIN 31 0.0031
93 HEPATIC MASS 6 0.0031
94 VAGINAL INFECTION 14 0.0030
95 ANAL PRURITUS 6 0.0029
96 DYSPEPSIA 284 0.0029
97 FOETAL GROWTH RESTRICTION 17 0.0028
98 DIVERTICULUM INTESTINAL 12 0.0027
99 INABILITY TO AFFORD MEDICATION 27 0.0027
100 THERAPEUTIC PRODUCT EFFECT DELAYED 12 0.0026
101 VENTRICULAR TACHYCARDIA 43 0.0026
102 HEPATIC FAILURE 78 0.0026
103 PRE-EXISTING CONDITION IMPROVED 16 0.0026
104 HUMERUS FRACTURE 12 0.0025
105 INTRAMEDULLARY ROD INSERTION 5 0.0024
106 INFLAMMATORY MARKER INCREASED 12 0.0024
107 CHEST INJURY 5 0.0024
108 THERAPEUTIC AGENT TOXICITY 8 0.0024
109 BLOOD ALBUMIN DECREASED 19 0.0024
110 HYPERPARATHYROIDISM SECONDARY 6 0.0024
111 VASODILATATION 6 0.0024
112 HYPOMAGNESAEMIA 33 0.0024
113 DYSLIPIDAEMIA 12 0.0024
114 HEPATIC NEOPLASM MALIGNANT 5 0.0024
115 LACTOSE INTOLERANCE 6 0.0023
116 ENDOCARDITIS 12 0.0023
117 THYROIDITIS 7 0.0023
118 CEREBELLAR SYNDROME 5 0.0023
119 ANORECTAL DISCOMFORT 12 0.0023
120 BLOOD PRESSURE SYSTOLIC INCREASED 44 0.0023
121 CANDIDIASIS 9 0.0022
122 ANAL ABSCESS 12 0.0022
123 ANORGASMIA 6 0.0022
124 APHTHOUS STOMATITIS 5 0.0022
125 LARGE INTESTINE POLYP 15 0.0022
126 HEPATIC PAIN 9 0.0021
127 PNEUMATOSIS INTESTINALIS 6 0.0021
128 LIP PAIN 6 0.0021
129 MAJOR DEPRESSION 15 0.0021
130 KETOACIDOSIS 15 0.0020
131 HEPATITIS ACUTE 13 0.0020
132 BLOOD PRESSURE INADEQUATELY CONTROLLED 12 0.0020
133 DIVERTICULUM 14 0.0020
134 HOSTILITY 5 0.0020
135 ATELECTASIS 19 0.0020
136 ELECTROCARDIOGRAM QT PROLONGED 70 0.0019
137 HEART RATE DECREASED 68 0.0019
138 HAEMATEMESIS 49 0.0019
139 YELLOW SKIN 9 0.0019
140 JOINT EFFUSION 13 0.0019
141 SNORING 7 0.0018
142 SINUS CONGESTION 25 0.0018
143 OCULAR ICTERUS 8 0.0018
144 HAEMORRHOIDAL HAEMORRHAGE 9 0.0018
145 HEPATIC NEOPLASM 6 0.0018
146 ANAEMIA 350 0.0018
147 HAEMORRHAGIC ANAEMIA 8 0.0018
148 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 6 0.0018
149 LOW DENSITY LIPOPROTEIN INCREASED 14 0.0018
150 HIGH DENSITY LIPOPROTEIN DECREASED 6 0.0018
151 LUNG CONSOLIDATION 5 0.0018
152 ULCER HAEMORRHAGE 12 0.0018
153 INSURANCE ISSUE 27 0.0018
154 MULTIPLE INJURIES 11 0.0017
155 FIBULA FRACTURE 5 0.0017
156 VENTRICULAR EXTRASYSTOLES 18 0.0017
157 HYPOPNOEA 6 0.0017
158 CATATONIA 9 0.0017
159 UMBILICAL HERNIA 8 0.0017
160 NECK INJURY 5 0.0017
161 SKIN TIGHTNESS 8 0.0017
162 RED CELL DISTRIBUTION WIDTH INCREASED 7 0.0017
163 WEIGHT DECREASED 463 0.0017
164 HEPATITIS C 20 0.0017
165 MENTAL STATUS CHANGES 46 0.0017
166 BURSITIS 20 0.0016
167 HYPOCALCAEMIA 31 0.0016
168 BLOOD MAGNESIUM DECREASED 14 0.0016
169 PSYCHOLOGICAL TRAUMA 14 0.0016
170 SMALL FOR DATES BABY 8 0.0016
171 UPPER GASTROINTESTINAL HAEMORRHAGE 27 0.0016
172 SKIN INFECTION 18 0.0016
173 DYSPHEMIA 7 0.0016
174 DECUBITUS ULCER 13 0.0016
175 BLOOD BILIRUBIN INCREASED 43 0.0016
176 PARANASAL SINUS DISCOMFORT 6 0.0016
177 BRADYCARDIA 84 0.0016
178 FACE INJURY 6 0.0016
179 OESOPHAGEAL ULCER 6 0.0016
180 BLOOD SODIUM DECREASED 29 0.0015
181 HAEMOGLOBIN INCREASED 7 0.0015
182 WOUND SECRETION 6 0.0015
183 VENTRICULAR FIBRILLATION 17 0.0015
184 EAR DISORDER 7 0.0015
185 PRODUCT ADMINISTRATION INTERRUPTED 12 0.0015
186 BREAST ENLARGEMENT 5 0.0015
187 BLOOD IRON DECREASED 18 0.0015
188 SINUS HEADACHE 9 0.0015
189 GASTRITIS EROSIVE 7 0.0015
190 FLANK PAIN 14 0.0015
191 HAEMORRHOIDS 29 0.0015
192 SINUS BRADYCARDIA 14 0.0014
193 FLUID OVERLOAD 21 0.0014
194 CONGESTIVE CARDIOMYOPATHY 6 0.0014
195 BACTERAEMIA 17 0.0014
196 CONSTIPATION 312 0.0014
197 LIVER DISORDER 63 0.0014
198 APHTHOUS ULCER 11 0.0014
199 BUNDLE BRANCH BLOCK LEFT 6 0.0014
200 HAEMATOCRIT DECREASED 28 0.0014
201 BLADDER DISORDER 14 0.0014
202 MELAENA 31 0.0014
203 GASTROINTESTINAL HAEMORRHAGE 117 0.0014
204 ABDOMINAL PAIN 324 0.0014
205 PHOTOSENSITIVITY REACTION 23 0.0014
206 CORONARY ARTERY STENOSIS 7 0.0014
207 FAECES DISCOLOURED 30 0.0014
208 PHOTOPHOBIA 26 0.0014
209 SLEEP APNOEA SYNDROME 26 0.0014
210 VARICOSE VEIN 7 0.0014
211 STOMACH DISCOMFORT 7 0.0014
212 HYPERBILIRUBINAEMIA 14 0.0014
213 RHINITIS ALLERGIC 6 0.0013
214 NYSTAGMUS 7 0.0013
215 FOOT FRACTURE 25 0.0013
216 BLOOD UREA INCREASED 22 0.0013
217 ECCHYMOSIS 9 0.0013
218 RIB FRACTURE 27 0.0013
219 GASTROINTESTINAL MOTILITY DISORDER 7 0.0013
220 ENCEPHALOPATHY 32 0.0013
221 DRUG ERUPTION 23 0.0013
222 ERYTHEMA 266 0.0013
223 EXTRASYSTOLES 9 0.0013
224 DEFAECATION URGENCY 9 0.0013
225 MIGRAINE 122 0.0013
226 CARDIAC MURMUR 11 0.0013
227 GASTRIC ULCER 24 0.0013
228 INTERNATIONAL NORMALISED RATIO INCREASED 36 0.0013
229 RENAL CYST 10 0.0013
230 HYPERLIPIDAEMIA 15 0.0013
231 CARDIOGENIC SHOCK 18 0.0013
232 HYPOVOLAEMIC SHOCK 6 0.0013
233 ANOREXIA 16 0.0012
234 HEART RATE IRREGULAR 28 0.0012
235 FUNGAL SKIN INFECTION 5 0.0012
236 HIATUS HERNIA 16 0.0012
237 HEPATIC STEATOSIS 23 0.0012
238 FIBROMYALGIA 30 0.0012
239 CELLULITIS 62 0.0012
240 POST PROCEDURAL INFECTION 10 0.0012
241 MUSCULOSKELETAL CHEST PAIN 19 0.0012
242 HAEMOGLOBIN DECREASED 126 0.0012
243 MICTURITION URGENCY 14 0.0012
244 KIDNEY INFECTION 24 0.0012
245 CARDIOMEGALY 15 0.0012
246 BLOOD PRESSURE FLUCTUATION 29 0.0012
247 GRAND MAL CONVULSION 11 0.0012
248 ECONOMIC PROBLEM 18 0.0012
249 PRODUCT DISTRIBUTION ISSUE 11 0.0012
250 NEPHROLITHIASIS 54 0.0012
251 ABSCESS LIMB 5 0.0012
252 AKATHISIA 16 0.0012
253 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 6 0.0012
254 PYREXIA 405 0.0012
255 VITAMIN D DECREASED 10 0.0012
256 WRIST FRACTURE 14 0.0012
257 HEPATIC CANCER 28 0.0012
258 SUPRAVENTRICULAR TACHYCARDIA 11 0.0011
259 MITRAL VALVE INCOMPETENCE 13 0.0011
260 WEIGHT FLUCTUATION 12 0.0011
261 GASTRITIS 30 0.0011
262 INTERNAL HAEMORRHAGE 13 0.0011
263 SEASONAL ALLERGY 16 0.0011
264 SCIATICA 18 0.0011
265 TYPE 2 DIABETES MELLITUS 38 0.0011
266 CHRONIC KIDNEY DISEASE 85 0.0011
267 JAUNDICE 30 0.0011
268 HYPOGLYCAEMIA 54 0.0011
269 END STAGE RENAL DISEASE 20 0.0011
270 ABDOMINAL HERNIA 5 0.0011
271 PERITONITIS BACTERIAL 11 0.0011
272 SPINAL COMPRESSION FRACTURE 9 0.0011
273 INCREASED TENDENCY TO BRUISE 10 0.0011
274 IRON DEFICIENCY ANAEMIA 10 0.0011
275 BLOOD CHOLESTEROL ABNORMAL 5 0.0011
276 LOWER GASTROINTESTINAL HAEMORRHAGE 8 0.0011
277 INCOHERENT 7 0.0011
278 FUNGAL INFECTION 36 0.0011
279 NEPHROGENIC ANAEMIA 5 0.0011
280 STREPTOCOCCAL INFECTION 6 0.0011
281 POLYP 7 0.0011
282 HYDRONEPHROSIS 8 0.0011
283 CHOLECYSTITIS ACUTE 6 0.0011
284 PULMONARY HYPERTENSION 22 0.0011
285 HEPATOCELLULAR CARCINOMA 8 0.0011
286 CONFUSIONAL STATE 170 0.0011
287 RED BLOOD CELL COUNT DECREASED 30 0.0010
288 LEFT VENTRICULAR DYSFUNCTION 7 0.0010
289 GASTRIC HAEMORRHAGE 12 0.0010
290 MYOPATHY 9 0.0010
291 POST PROCEDURAL COMPLICATION 20 0.0010
292 HYSTERECTOMY 9 0.0010
293 BRONCHIECTASIS 7 0.0010
294 APHAGIA 5 0.0010
295 THYROID DISORDER 16 0.0010
296 CHOLELITHIASIS 34 0.0010
297 ATRIOVENTRICULAR BLOCK 8 0.0010
298 STRESS CARDIOMYOPATHY 6 0.0010
299 BLOOD POTASSIUM DECREASED 31 0.0010
300 URINE OUTPUT DECREASED 9 0.0010
301 HYPOVOLAEMIA 6 0.0010
302 PSYCHOMOTOR HYPERACTIVITY 17 0.0010
303 BLOOD PRESSURE INCREASED 156 0.0010
304 RENAL TUBULAR NECROSIS 10 0.0010
305 BREATH SOUNDS ABNORMAL 5 0.0010
306 MUSCULOSKELETAL PAIN 53 0.0010
307 HYPERSOMNIA 29 0.0010
308 MULTIPLE DRUG OVERDOSE 5 0.0010
309 ABDOMINAL TENDERNESS 5 0.0010
310 ATRIAL FLUTTER 8 0.0010
311 GASTROENTERITIS VIRAL 18 0.0010
312 OEDEMA 54 0.0010
313 RED BLOOD CELL SEDIMENTATION RATE INCREASED 11 0.0010
314 SQUAMOUS CELL CARCINOMA OF SKIN 6 0.0010
315 DRUG INEFFECTIVE 1307 0.0010
316 LETHARGY 57 0.0010
317 DRUG TOLERANCE 5 0.0010
318 HYPOKALAEMIA 45 0.0010
319 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 10 0.0010
320 HAIR TEXTURE ABNORMAL 13 0.0010
321 HAIR DISORDER 8 0.0010
322 HEADACHE 608 0.0010
323 TONGUE DISORDER 7 0.0010
324 DRUG LEVEL INCREASED 16 0.0010
325 MYOCARDIAL ISCHAEMIA 11 0.0010
326 PLATELET COUNT DECREASED 103 0.0010
327 BACTERIAL INFECTION 18 0.0010
328 CHOLECYSTECTOMY 11 0.0010
329 MALAISE 421 0.0010
330 SINUS DISORDER 19 0.0010
331 LACERATION 9 0.0010
332 NERVOUSNESS 50 0.0010
333 CARDIAC ARREST 79 0.0010
334 BLOOD CREATININE INCREASED 62 0.0009
335 BLOOD LACTIC ACID INCREASED 5 0.0009
336 INFUSION SITE ERYTHEMA 8 0.0009
337 CANDIDA INFECTION 16 0.0009
338 CEREBRAL DISORDER 7 0.0009
339 PRODUCT PHYSICAL ISSUE 19 0.0009
340 ORAL DISCOMFORT 13 0.0009
341 BODY HEIGHT DECREASED 10 0.0009
342 DISORIENTATION 37 0.0009
343 FOOD POISONING 5 0.0009
344 PSEUDOMONAS INFECTION 8 0.0009
345 PALPITATIONS 109 0.0009
346 CARDIAC FLUTTER 6 0.0009
347 SINUSITIS 95 0.0009
348 BLOOD TEST ABNORMAL 13 0.0009
349 COELIAC DISEASE 9 0.0009
350 CLOSTRIDIUM DIFFICILE INFECTION 20 0.0009
351 HEPATOMEGALY 9 0.0009
352 IMPAIRED HEALING 30 0.0009
353 JAW DISORDER 5 0.0009
354 PROCEDURAL COMPLICATION 7 0.0009
355 THINKING ABNORMAL 17 0.0009
356 COMPLETED SUICIDE 76 0.0009
357 WALKING AID USER 6 0.0009
358 RENAL INJURY 27 0.0009
359 COLD SWEAT 16 0.0009
360 TOOTH FRACTURE 10 0.0009
361 WITHDRAWAL SYNDROME 38 0.0009
362 GASTRIC ULCER HAEMORRHAGE 5 0.0009
363 DRY MOUTH 73 0.0009
364 PELVIC FRACTURE 7 0.0009
365 CHOLECYSTITIS CHRONIC 6 0.0009
366 OEDEMA PERIPHERAL 109 0.0009
367 ATRIAL FIBRILLATION 87 0.0009
368 ELECTROCARDIOGRAM ABNORMAL 7 0.0009
369 TRANSIENT ISCHAEMIC ATTACK 30 0.0009
370 HYPONATRAEMIA 50 0.0009
371 IRRITABLE BOWEL SYNDROME 19 0.0009
372 EYE INFECTION 10 0.0009
373 IMPAIRED DRIVING ABILITY 10 0.0009
374 BONE DISORDER 16 0.0009
375 BLOOD TESTOSTERONE DECREASED 6 0.0009
376 GASTRIC DISORDER 30 0.0009
377 BLOOD DISORDER 7 0.0009
378 ORAL HERPES 17 0.0009
379 RHINITIS 7 0.0009
380 MULTI-ORGAN FAILURE 15 0.0009
381 RENAL FAILURE 115 0.0009
382 FLUID RETENTION 44 0.0009
383 COORDINATION ABNORMAL 12 0.0009
384 BLOOD PRESSURE DECREASED 57 0.0009
385 BLOOD COUNT ABNORMAL 13 0.0009
386 ABNORMAL FAECES 7 0.0009
387 NAUSEA 675 0.0009
388 HYPERAESTHESIA 7 0.0009
389 ABASIA 21 0.0008
390 RENAL FAILURE ACUTE 36 0.0008
391 DECREASED INTEREST 5 0.0008
392 ABDOMINAL DISTENSION 88 0.0008
393 CHEST DISCOMFORT 86 0.0008
394 CARDIAC PACEMAKER INSERTION 5 0.0008
395 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 46 0.0008
396 PAIN 514 0.0008
397 OXYGEN SATURATION DECREASED 47 0.0008
398 GOUT 15 0.0008
399 DECREASED ACTIVITY 9 0.0008
400 PRURITUS GENERALISED 18 0.0008
401 OSTEOMYELITIS 15 0.0008
402 HYPERKALAEMIA 29 0.0008
403 EYE HAEMORRHAGE 11 0.0008
404 NOCTURIA 10 0.0008
405 TREATMENT NONCOMPLIANCE 45 0.0008
406 NO THERAPEUTIC RESPONSE 10 0.0008
407 PNEUMOTHORAX 13 0.0008
408 AMNESIA 53 0.0008
409 BRONCHITIS 60 0.0008
410 HOSPICE CARE 8 0.0008
411 GENERALISED OEDEMA 10 0.0008
412 HAIR COLOUR CHANGES 10 0.0008
413 HYPOTENSION 161 0.0008
414 OSTEOARTHRITIS 34 0.0008
415 OVARIAN CYST 8 0.0008
416 ANHEDONIA 21 0.0008
417 SPINAL FRACTURE 16 0.0008
418 NASAL DRYNESS 5 0.0008
419 BRAIN INJURY 8 0.0008
420 HEART RATE INCREASED 79 0.0008
421 RETCHING 17 0.0008
422 DISTURBANCE IN ATTENTION 43 0.0008
423 DRUG INTOLERANCE 77 0.0008
424 GROIN PAIN 7 0.0008
425 HEAD DISCOMFORT 14 0.0008
426 EAR INFECTION 21 0.0008
427 AORTIC ANEURYSM 6 0.0008
428 RESPIRATORY RATE INCREASED 7 0.0008
429 DYSPHONIA 46 0.0008
430 URINARY TRACT INFECTION 134 0.0008
431 FACIAL PAIN 7 0.0008
432 MENTAL IMPAIRMENT 19 0.0008
433 DEPRESSED LEVEL OF CONSCIOUSNESS 31 0.0008
434 PULMONARY OEDEMA 35 0.0008
435 SYNCOPE 78 0.0008
436 HAEMOLYSIS 6 0.0008
437 INFUSION SITE PAIN 10 0.0008
438 ANKLE FRACTURE 12 0.0008
439 UNRESPONSIVE TO STIMULI 20 0.0008
440 POST PROCEDURAL HAEMORRHAGE 9 0.0008
441 EJECTION FRACTION DECREASED 12 0.0008
442 EAR PAIN 15 0.0008
443 ACUTE KIDNEY INJURY 118 0.0008
444 ANGINA UNSTABLE 5 0.0008
445 BLOOD ALKALINE PHOSPHATASE INCREASED 19 0.0008
446 NERVE COMPRESSION 7 0.0008
447 HEAD INJURY 24 0.0008
448 DEHYDRATION 101 0.0008
449 NASAL DISCOMFORT 6 0.0008
450 INTERVERTEBRAL DISC DEGENERATION 7 0.0008
451 SUDDEN DEATH 8 0.0008
452 ULCER 12 0.0008
453 APPETITE DISORDER 5 0.0008
454 OBESITY 12 0.0008
455 NECK PAIN 42 0.0008
456 NEPHROPATHY 7 0.0007
457 SENSORY DISTURBANCE 12 0.0007
458 HIP FRACTURE 24 0.0007
459 ARTERIOSCLEROSIS 7 0.0007
460 METASTASES TO LIVER 13 0.0007
461 SHOCK 17 0.0007
462 BLOOD POTASSIUM INCREASED 12 0.0007
463 BACK DISORDER 12 0.0007
464 MUSCLE TWITCHING 17 0.0007
465 BLOOD TRIGLYCERIDES INCREASED 13 0.0007
466 SEPTIC SHOCK 32 0.0007
467 EPISTAXIS 55 0.0007
468 ACUTE RESPIRATORY DISTRESS SYNDROME 13 0.0007
469 DIABETES MELLITUS INADEQUATE CONTROL 13 0.0007
470 ABNORMAL LOSS OF WEIGHT 5 0.0007
471 GALLBLADDER DISORDER 13 0.0007
472 PERIPHERAL COLDNESS 10 0.0007
473 FLUSHING 74 0.0007
474 RESPIRATORY ARREST 20 0.0007
475 GENERALISED TONIC-CLONIC SEIZURE 12 0.0007
476 ILEUS 9 0.0007
477 DEEP VEIN THROMBOSIS 47 0.0007
478 DENTAL CARIES 8 0.0007
479 PAIN IN EXTREMITY 213 0.0007
480 FEELING COLD 20 0.0007
481 ARRHYTHMIA 34 0.0007
482 MALNUTRITION 8 0.0007
483 NASAL CONGESTION 42 0.0007
484 EMOTIONAL DISORDER 22 0.0007
485 ACTIVITIES OF DAILY LIVING IMPAIRED 14 0.0007
486 BLOOD PRESSURE ABNORMAL 14 0.0007
487 JOINT INJURY 15 0.0007
488 HAEMATURIA 24 0.0007
489 PRESYNCOPE 17 0.0007
490 STAPHYLOCOCCAL INFECTION 23 0.0007
491 PERIPHERAL SWELLING 107 0.0007
492 OFF LABEL USE 607 0.0007
493 PHARMACEUTICAL PRODUCT COMPLAINT 18 0.0007
494 RESPIRATORY TRACT CONGESTION 11 0.0007
495 CHEST PAIN 128 0.0007
496 MADAROSIS 8 0.0007
497 HYPOTHYROIDISM 22 0.0007
498 DRY THROAT 7 0.0007
499 FALL 229 0.0007
500 DIARRHOEA 444 0.0007
501 LIVER FUNCTION TEST ABNORMAL 20 0.0007
502 DIZZINESS 343 0.0007
503 SLUGGISHNESS 7 0.0007
504 CONTUSION 66 0.0007
505 COGNITIVE DISORDER 32 0.0007
506 CARDIAC FAILURE CONGESTIVE 55 0.0007
507 BACK PAIN 159 0.0007
508 WEIGHT INCREASED 153 0.0007
509 INITIAL INSOMNIA 7 0.0007
510 ASTHENIA 256 0.0007
511 FATIGUE 530 0.0007
512 INFLUENZA LIKE ILLNESS 56 0.0007
513 LOSS OF CONSCIOUSNESS 87 0.0007
514 MUSCLE SPASMS 124 0.0007
515 DYSGEUSIA 50 0.0007
516 PRODUCT PRESCRIBING ERROR 16 0.0007
517 CHOLECYSTITIS 8 0.0007
518 POLLAKIURIA 28 0.0007
519 BALANCE DISORDER 58 0.0007
520 HAEMOLYTIC ANAEMIA 6 0.0007
521 GASTROINTESTINAL INFECTION 6 0.0007
522 MUSCLE RIGIDITY 8 0.0007
523 ANAL INCONTINENCE 6 0.0007
524 PSORIATIC ARTHROPATHY 27 0.0007
525 CHROMATURIA 15 0.0007
526 HYPOAESTHESIA ORAL 10 0.0007
527 ANGINA PECTORIS 19 0.0007
528 JOINT DISLOCATION 7 0.0007
529 DRUG TOXICITY 9 0.0007
530 CORONARY ARTERY DISEASE 20 0.0007
531 RENAL PAIN 7 0.0007
532 PRODUCT SUBSTITUTION ISSUE 38 0.0007
533 RESTLESS LEGS SYNDROME 12 0.0007
534 WHEEZING 39 0.0007
535 EATING DISORDER 14 0.0007
536 PLEURAL EFFUSION 40 0.0007
537 EYE PAIN 37 0.0007
538 PNEUMONIA BACTERIAL 6 0.0007
539 RESPIRATORY DISTRESS 18 0.0007
540 LIVER FUNCTION TEST INCREASED 14 0.0007
541 HYPERHIDROSIS 84 0.0007
542 WHITE BLOOD CELL COUNT INCREASED 25 0.0007
543 UROSEPSIS 6 0.0006
544 SEDATION 17 0.0006
545 JOINT STIFFNESS 17 0.0006
546 CONCUSSION 5 0.0006
547 FULL BLOOD COUNT DECREASED 13 0.0006
548 PHARYNGITIS 8 0.0006
549 MASS 9 0.0006
550 DELUSION 10 0.0006
551 THERAPY INTERRUPTED 46 0.0006
552 MIDDLE INSOMNIA 12 0.0006
553 MUSCULAR WEAKNESS 73 0.0006
554 GASTROINTESTINAL INFLAMMATION 5 0.0006
555 MULTIPLE ALLERGIES 5 0.0006
556 BODY TEMPERATURE INCREASED 13 0.0006
557 WHITE BLOOD CELL COUNT DECREASED 69 0.0006
558 FLATULENCE 36 0.0006
559 DIALYSIS 9 0.0006
560 GLYCOSYLATED HAEMOGLOBIN INCREASED 16 0.0006
561 SINUS TACHYCARDIA 9 0.0006
562 SPINAL DISORDER 6 0.0006
563 BRAIN OEDEMA 8 0.0006
564 PRODUCT PACKAGING ISSUE 6 0.0006
565 VIRAL INFECTION 21 0.0006
566 INSOMNIA 168 0.0006
567 CYSTITIS 20 0.0006
568 LIMB INJURY 17 0.0006
569 DECREASED APPETITE 145 0.0006
570 HYPERTHYROIDISM 9 0.0006
571 COMPLICATION ASSOCIATED WITH DEVICE 9 0.0006
572 DIZZINESS POSTURAL 6 0.0006
573 HYPERTENSION 131 0.0006
574 DRUG INTERACTION 98 0.0006
575 DIPLOPIA 16 0.0006
576 LOWER RESPIRATORY TRACT INFECTION 28 0.0006
577 ABNORMAL DREAMS 17 0.0006
578 SCAB 7 0.0006
579 PLATELET COUNT INCREASED 8 0.0006
580 DIVERTICULITIS 17 0.0006
581 MEMORY IMPAIRMENT 84 0.0006
582 DYSPNOEA EXERTIONAL 23 0.0006
583 THERAPY CHANGE 6 0.0006
584 KNEE OPERATION 6 0.0006
585 BODY TEMPERATURE DECREASED 6 0.0006
586 IMPAIRED WORK ABILITY 13 0.0006
587 IMMUNE SYSTEM DISORDER 8 0.0006
588 METASTASES TO LUNG 7 0.0006
589 DRUG-INDUCED LIVER INJURY 19 0.0006
590 PULMONARY MASS 9 0.0006
591 SOPOR 8 0.0006
592 SOMNOLENCE 121 0.0006
593 COAGULOPATHY 10 0.0006
594 ARTHRITIS 47 0.0006
595 APHASIA 18 0.0006
596 COUGH 166 0.0006
597 NIGHT SWEATS 19 0.0006
598 TOOTH ABSCESS 6 0.0006
599 MOTOR DYSFUNCTION 6 0.0006
600 PALLOR 16 0.0006
601 CATARACT 35 0.0006
602 IMPAIRED GASTRIC EMPTYING 8 0.0006
603 HEPATOTOXICITY 13 0.0006
604 OSTEOPOROSIS 24 0.0006
605 IRRITABILITY 35 0.0006
606 UNEVALUABLE EVENT 44 0.0006
607 TEMPERATURE INTOLERANCE 6 0.0006
608 ANURIA 5 0.0006
609 JOINT SWELLING 70 0.0006
610 RASH GENERALISED 15 0.0006
611 DRUG EFFECT INCOMPLETE 21 0.0006
612 RHABDOMYOLYSIS 24 0.0006
613 BRAIN FOG 9 0.0006
614 ROAD TRAFFIC ACCIDENT 24 0.0006
615 LOCAL SWELLING 10 0.0006
616 TRANSFUSION 6 0.0006
617 CYANOSIS 9 0.0006
618 THROMBOCYTOPENIA 64 0.0006
619 RASH PRURITIC 31 0.0006
620 AGITATION 42 0.0006
621 GLOMERULAR FILTRATION RATE DECREASED 7 0.0006
622 HERNIA 11 0.0006
623 NEUROPATHY PERIPHERAL 54 0.0006
624 INCONTINENCE 6 0.0006
625 CLOSTRIDIUM DIFFICILE COLITIS 6 0.0006
626 ASPARTATE AMINOTRANSFERASE INCREASED 30 0.0006
627 CYST 7 0.0006
628 DYSPNOEA 319 0.0006
629 UPPER RESPIRATORY TRACT INFECTION 26 0.0006
630 BREAST PAIN 6 0.0006
631 HYPOAESTHESIA 84 0.0006
632 MOVEMENT DISORDER 18 0.0006
633 GASTROOESOPHAGEAL REFLUX DISEASE 45 0.0006
634 SUBDURAL HAEMATOMA 8 0.0006
635 RENAL DISORDER 26 0.0006
636 DYSARTHRIA 21 0.0006
637 VERTIGO 34 0.0006
638 BLOOD CHOLESTEROL INCREASED 26 0.0006
639 RHINORRHOEA 36 0.0006
640 HERPES ZOSTER 32 0.0006
641 MUSCLE TIGHTNESS 9 0.0006
642 PANCYTOPENIA 31 0.0006
643 FEELING HOT 34 0.0006
644 CHILLS 65 0.0006
645 SWELLING FACE 36 0.0006
646 UPPER LIMB FRACTURE 11 0.0006
647 SKIN LACERATION 6 0.0006
648 HYPOKINESIA 8 0.0006
649 CARDIO-RESPIRATORY ARREST 23 0.0005
650 LIMB DISCOMFORT 17 0.0005
651 DEPRESSED MOOD 29 0.0005
652 ASPIRATION 6 0.0005
653 MYALGIA 93 0.0005
654 RASH MACULAR 19 0.0005
655 GAIT DISTURBANCE 104 0.0005
656 FEEDING DISORDER 11 0.0005
657 CARDIOMYOPATHY 8 0.0005
658 URINARY INCONTINENCE 16 0.0005
659 ALOPECIA 106 0.0005
660 INFECTION 78 0.0005
661 GAIT INABILITY 18 0.0005
662 HAEMOPTYSIS 15 0.0005
663 LOCALISED INFECTION 13 0.0005
664 THROAT IRRITATION 24 0.0005
665 OCULAR DISCOMFORT 6 0.0005
666 BEDRIDDEN 7 0.0005
667 NASOPHARYNGITIS 98 0.0005
668 ABORTION INDUCED 5 0.0005
669 ANXIETY 151 0.0005
670 MULTIPLE ORGAN DYSFUNCTION SYNDROME 15 0.0005
671 OSTEOPENIA 8 0.0005
672 DEVICE FAILURE 8 0.0005
673 INCREASED APPETITE 10 0.0005
674 TINNITUS 24 0.0005
675 SKIN DISCOLOURATION 24 0.0005
676 FEAR 14 0.0005
677 DEVICE RELATED INFECTION 8 0.0005
678 AFFECT LABILITY 5 0.0005
679 ARTHRALGIA 216 0.0005
680 GLAUCOMA 10 0.0005
681 OROPHARYNGEAL PAIN 48 0.0005
682 ORTHOSTATIC HYPOTENSION 9 0.0005
683 ERUCTATION 10 0.0005
684 PRESCRIBED OVERDOSE 10 0.0005
685 ELECTROLYTE IMBALANCE 6 0.0005
686 DYSURIA 19 0.0005
687 ABDOMINAL PAIN LOWER 13 0.0005
688 DYSSTASIA 15 0.0005
689 FEELING ABNORMAL 123 0.0005
690 AUTOIMMUNE DISORDER 5 0.0005
691 BASAL CELL CARCINOMA 8 0.0005
692 CHOKING 10 0.0005
693 HYPOXIA 18 0.0005
694 INFLUENZA 57 0.0005
695 PNEUMONIA 165 0.0005
696 MENTAL DISORDER 22 0.0005
697 DISEASE RECURRENCE 24 0.0005
698 INTERVERTEBRAL DISC PROTRUSION 11 0.0005
699 PARAESTHESIA 79 0.0005
700 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 26 0.0005
701 THROMBOSIS 40 0.0005
702 TOOTHACHE 9 0.0005
703 BLINDNESS UNILATERAL 7 0.0005
704 APPLICATION SITE ERYTHEMA 13 0.0005
705 DYSPHAGIA 47 0.0005
706 TRANSAMINASES INCREASED 11 0.0005
707 TOOTH DISORDER 11 0.0005
708 HYPOTHERMIA 5 0.0005
709 PANIC ATTACK 18 0.0005
710 DEPRESSION 112 0.0005
711 RESTLESSNESS 18 0.0005
712 DRUG LEVEL DECREASED 5 0.0005
713 ABDOMINAL PAIN UPPER 101 0.0005
714 INJECTION SITE URTICARIA 12 0.0005
715 HOSPITALISATION 75 0.0005
716 DRUG DOSE OMISSION 80 0.0005
717 DRUG EFFECT DECREASED 26 0.0005
718 PSORIASIS 63 0.0005
719 TOOTH EXTRACTION 6 0.0005
720 PRODUCTIVE COUGH 23 0.0005
721 LYMPHADENOPATHY 17 0.0005
722 SKIN DISORDER 16 0.0005
723 URINARY RETENTION 16 0.0005
724 VOMITING 225 0.0005
725 HAEMORRHAGE 50 0.0005
726 ABDOMINAL DISCOMFORT 80 0.0005
727 CONDITION AGGRAVATED 145 0.0005
728 FRACTURE 9 0.0005
729 BLOOD GLUCOSE INCREASED 89 0.0005
730 ALANINE AMINOTRANSFERASE INCREASED 29 0.0005
731 BURNING SENSATION 33 0.0005
732 LOWER LIMB FRACTURE 9 0.0005
733 HAEMORRHAGE INTRACRANIAL 7 0.0005
734 CRYING 17 0.0005
735 ADVERSE DRUG REACTION 42 0.0005
736 SEIZURE 54 0.0005
737 ROTATOR CUFF SYNDROME 6 0.0005
738 VISION BLURRED 64 0.0005
739 INFLAMMATION 24 0.0005
740 TACHYCARDIA 41 0.0005
741 RASH ERYTHEMATOUS 22 0.0005
742 BIPOLAR DISORDER 5 0.0005
743 BACK INJURY 5 0.0005
744 DEAFNESS 12 0.0005
745 EPILEPSY 14 0.0005
746 TREMOR 76 0.0005
747 SEPSIS 51 0.0005
748 BLOOD GLUCOSE FLUCTUATION 5 0.0005
749 DISABILITY 9 0.0005
750 LYMPHOCYTE COUNT DECREASED 8 0.0005
751 NEURALGIA 11 0.0005
752 TOXICITY TO VARIOUS AGENTS 76 0.0005
753 NERVE INJURY 5 0.0004
754 SWOLLEN TONGUE 14 0.0004
755 PRODUCT USE ISSUE 84 0.0004
756 CEREBRAL HAEMORRHAGE 16 0.0004
757 THERAPEUTIC RESPONSE UNEXPECTED 20 0.0004
758 PANCREATITIS ACUTE 10 0.0004
759 BONE PAIN 26 0.0004
760 HALLUCINATION, AUDITORY 7 0.0004
761 LABORATORY TEST ABNORMAL 13 0.0004
762 WRONG TECHNIQUE IN DRUG USAGE PROCESS 16 0.0004
763 HYPERGLYCAEMIA 16 0.0004
764 SWELLING 41 0.0004
765 CORONARY ARTERY OCCLUSION 6 0.0004
766 ACCIDENTAL OVERDOSE 16 0.0004
767 BLOOD GLUCOSE DECREASED 21 0.0004
768 CONVULSION 25 0.0004
769 INTENTIONAL PRODUCT USE ISSUE 38 0.0004
770 CONJUNCTIVITIS 8 0.0004
771 INTENTIONAL DRUG MISUSE 9 0.0004
772 HYPOPHAGIA 11 0.0004
773 HEPATITIS 11 0.0004
774 APHONIA 6 0.0004
775 THERAPY CESSATION 22 0.0004
776 PRODUCT DOSE OMISSION IN ERROR 12 0.0004
777 DRUG ADMINISTRATION ERROR 13 0.0004
778 RESPIRATORY TRACT INFECTION 11 0.0004
779 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 30 0.0004
780 BLOOD URINE PRESENT 8 0.0004
781 DRY EYE 21 0.0004
782 BRONCHOSPASM 6 0.0004
783 SKIN CANCER 9 0.0004
784 BLINDNESS 17 0.0004
785 NEUTROPHIL COUNT DECREASED 17 0.0004
786 EYE PRURITUS 14 0.0004
787 RENAL IMPAIRMENT 35 0.0004
788 NERVOUS SYSTEM DISORDER 13 0.0004
789 PRURITUS 160 0.0004
790 PULMONARY ARTERIAL HYPERTENSION 6 0.0004
791 URTICARIA 69 0.0004
792 BREAST CANCER FEMALE 11 0.0004
793 PARANOIA 7 0.0004
794 INJECTION SITE EXTRAVASATION 5 0.0004
795 HYPERCALCAEMIA 5 0.0004
796 SKIN HAEMORRHAGE 6 0.0004
797 IMMUNODEFICIENCY 6 0.0004
798 CEREBROVASCULAR ACCIDENT 68 0.0004
799 AGEUSIA 10 0.0004
800 SPEECH DISORDER 21 0.0004
801 PNEUMONIA ASPIRATION 10 0.0004
802 HOT FLUSH 30 0.0004
803 MEDICATION ERROR 22 0.0004
804 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 19 0.0004
805 VISUAL IMPAIRMENT 49 0.0004
806 EYE DISORDER 13 0.0004
807 PRODUCT AVAILABILITY ISSUE 9 0.0004
808 ILL-DEFINED DISORDER 24 0.0004
809 DIABETES MELLITUS 30 0.0004
810 DISCOMFORT 24 0.0004
811 DRUG DISPENSING ERROR 6 0.0004
812 HIP ARTHROPLASTY 6 0.0004
813 INTRAOCULAR PRESSURE INCREASED 5 0.0004
814 TARDIVE DYSKINESIA 11 0.0004
815 ILLNESS 40 0.0004
816 EMOTIONAL DISTRESS 47 0.0004
817 FEMUR FRACTURE 12 0.0004
818 HAEMATOMA 10 0.0004
819 TOOTH LOSS 8 0.0004
820 SLEEP DISORDER 27 0.0004
821 HEPATIC ENZYME INCREASED 26 0.0004
822 MOUTH ULCERATION 8 0.0004
823 OCULAR HYPERAEMIA 18 0.0004
824 BLOOD GLUCOSE ABNORMAL 7 0.0004
825 PANCREATITIS 20 0.0004
826 THERAPY NON-RESPONDER 17 0.0004
827 PREMATURE DELIVERY 6 0.0004
828 MUSCULOSKELETAL STIFFNESS 33 0.0004
829 MOBILITY DECREASED 27 0.0004
830 DIABETIC KETOACIDOSIS 9 0.0004
831 DELIRIUM 13 0.0004
832 JOINT RANGE OF MOTION DECREASED 5 0.0004
833 RASH 162 0.0004
834 POOR QUALITY SLEEP 8 0.0004
835 RESPIRATORY FAILURE 27 0.0004
836 LIVER INJURY 9 0.0004
837 EYE IRRITATION 21 0.0004
838 MANIA 6 0.0004
839 ACUTE RESPIRATORY FAILURE 7 0.0004
840 APPLICATION SITE PAIN 8 0.0004
841 STOMATITIS 22 0.0004
842 TREATMENT FAILURE 30 0.0004
843 PRODUCT USE IN UNAPPROVED INDICATION 89 0.0004
844 INJECTION SITE RASH 11 0.0004
845 SURGERY 21 0.0004
846 SKIN FISSURES 7 0.0004
847 GLOSSODYNIA 8 0.0004
848 CARPAL TUNNEL SYNDROME 5 0.0004
849 RASH PAPULAR 8 0.0004
850 INJURY 25 0.0004
851 PAIN IN JAW 10 0.0004
852 ERECTILE DYSFUNCTION 9 0.0004
853 EYE SWELLING 13 0.0003
854 MUSCULOSKELETAL DISCOMFORT 6 0.0003
855 SKIN ULCER 9 0.0003
856 PULMONARY EMBOLISM 33 0.0003
857 MOOD SWINGS 11 0.0003
858 METABOLIC ACIDOSIS 11 0.0003
859 ANAPHYLACTIC REACTION 19 0.0003
860 PRODUCT DOSE OMISSION ISSUE 101 0.0003
861 APATHY 5 0.0003
862 NEUROTOXICITY 6 0.0003
863 BLISTER 19 0.0003
864 PERITONITIS 7 0.0003
865 COMA 16 0.0003
866 THIRST 6 0.0003
867 HYPERSENSITIVITY 62 0.0003
868 KNEE ARTHROPLASTY 7 0.0003
869 PREMATURE BABY 10 0.0003
870 FOETAL EXPOSURE DURING PREGNANCY 27 0.0003
871 SKIN EXFOLIATION 28 0.0003
872 LEUKOCYTOSIS 6 0.0003
873 INTENTIONAL PRODUCT MISUSE 29 0.0003
874 VISUAL ACUITY REDUCED 11 0.0003
875 PELVIC PAIN 6 0.0003
876 SKIN LESION 9 0.0003
877 ASTHMA 37 0.0003
878 INCORRECT PRODUCT ADMINISTRATION DURATION 7 0.0003
879 AGRANULOCYTOSIS 6 0.0003
880 HEPATIC FUNCTION ABNORMAL 12 0.0003
881 DYSKINESIA 13 0.0003
882 RHEUMATOID ARTHRITIS 36 0.0003
883 INTENTIONAL DOSE OMISSION 9 0.0003
884 INJECTION SITE PRURITUS 21 0.0003
885 ABSCESS 5 0.0003
886 THERAPEUTIC RESPONSE DECREASED 19 0.0003
887 ORAL PAIN 7 0.0003
888 SNEEZING 7 0.0003
889 CARDIAC FAILURE 25 0.0003
890 CARDIAC DISORDER 29 0.0003
891 PRODUCT QUALITY ISSUE 42 0.0003
892 LACTIC ACIDOSIS 10 0.0003
893 PRODUCT DOSE OMISSION 20 0.0003
894 SUICIDAL IDEATION 28 0.0003
895 ABNORMAL BEHAVIOUR 12 0.0003
896 GENERAL PHYSICAL HEALTH DETERIORATION 35 0.0003
897 C-REACTIVE PROTEIN INCREASED 11 0.0003
898 LACRIMATION INCREASED 9 0.0003
899 PAIN OF SKIN 8 0.0003
900 PRODUCT ADMINISTRATION ERROR 6 0.0003
901 COVID-19 52 0.0003
902 INJECTION SITE WARMTH 6 0.0003
903 MYOCARDIAL INFARCTION 50 0.0003
904 DEMENTIA 8 0.0003
905 AMENORRHOEA 5 0.0003
906 SYSTEMIC LUPUS ERYTHEMATOSUS 10 0.0003
907 ISCHAEMIC STROKE 5 0.0003
908 HYPOACUSIS 12 0.0003
909 HALLUCINATION 21 0.0003
910 INCORRECT DOSE ADMINISTERED 63 0.0003
911 INJECTION SITE SWELLING 21 0.0003
912 UNDERDOSE 20 0.0003
913 DRUG WITHDRAWAL SYNDROME 24 0.0003
914 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 49 0.0003
915 EXTRA DOSE ADMINISTERED 11 0.0003
916 ACUTE MYOCARDIAL INFARCTION 8 0.0003
917 DISEASE PROGRESSION 32 0.0003
918 LIP SWELLING 9 0.0003
919 STEVENS-JOHNSON SYNDROME 6 0.0003
920 ARTHROPATHY 15 0.0003
921 INTERSTITIAL LUNG DISEASE 13 0.0003
922 THERAPEUTIC PRODUCT EFFECT DECREASED 12 0.0003
923 ECZEMA 14 0.0003
924 LUNG DISORDER 13 0.0003
925 APPLICATION SITE PRURITUS 6 0.0003
926 CONTRAINDICATED PRODUCT ADMINISTERED 8 0.0003
927 FEELING JITTERY 5 0.0003
928 DRUG PRESCRIBING ERROR 5 0.0003
929 PERICARDIAL EFFUSION 6 0.0003
930 INJECTION SITE ERYTHEMA 32 0.0003
931 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 6 0.0003
932 MOOD ALTERED 7 0.0003
933 MENORRHAGIA 5 0.0003
934 MATERNAL EXPOSURE DURING PREGNANCY 22 0.0002
935 CEREBRAL INFARCTION 6 0.0002
936 DEATH 211 0.0002
937 INJECTION SITE MASS 9 0.0002
938 BLOOD CREATINE PHOSPHOKINASE INCREASED 7 0.0002
939 EXPOSURE DURING PREGNANCY 15 0.0002
940 THERAPEUTIC RESPONSE SHORTENED 8 0.0002
941 OVERDOSE 52 0.0002
942 SKIN IRRITATION 11 0.0002
943 DRY SKIN 32 0.0002
944 ADVERSE EVENT 22 0.0002
945 INJECTION SITE BRUISING 19 0.0002
946 INJECTION SITE HAEMORRHAGE 19 0.0002
947 ACNE 18 0.0002
948 RESPIRATORY DISORDER 7 0.0002
949 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 6 0.0002
950 INJECTION SITE REACTION 16 0.0002
951 EXPOSURE VIA SKIN CONTACT 6 0.0002
952 ALTERED STATE OF CONSCIOUSNESS 5 0.0002
953 MULTIPLE SCLEROSIS 11 0.0002
954 INJECTION SITE PAIN 70 0.0002
955 GAMMA-GLUTAMYLTRANSFERASE INCREASED 5 0.0002
956 AGGRESSION 11 0.0002
957 MULTIPLE SCLEROSIS RELAPSE 15 0.0002
958 WOUND 6 0.0002
959 INTESTINAL OBSTRUCTION 8 0.0002
960 GASTROINTESTINAL DISORDER 19 0.0002
961 FEBRILE NEUTROPENIA 14 0.0002
962 SKIN BURNING SENSATION 15 0.0002
963 PANCREATIC CARCINOMA 6 0.0002
964 MALIGNANT NEOPLASM PROGRESSION 21 0.0002
965 BREAST CANCER 19 0.0002
966 PSYCHOTIC DISORDER 6 0.0002
967 NIGHTMARE 7 0.0002
968 EXTRAPYRAMIDAL DISORDER 5 0.0002
969 CARDIOVASCULAR DISORDER 5 0.0002
970 MUCOSAL INFLAMMATION 5 0.0002
971 DEVICE MALFUNCTION 13 0.0002
972 VAGINAL HAEMORRHAGE 8 0.0002
973 EXPIRED PRODUCT ADMINISTERED 6 0.0002
974 NEUTROPENIA 24 0.0002
975 NEOPLASM PROGRESSION 6 0.0002
976 PRODUCT ADHESION ISSUE 6 0.0002
977 DEVICE ISSUE 15 0.0002
978 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 33 0.0002
979 DEVICE DISLOCATION 7 0.0002
980 ACCIDENTAL EXPOSURE TO PRODUCT 16 0.0002
981 PLASMA CELL MYELOMA 6 0.0002
982 NEOPLASM MALIGNANT 10 0.0001
983 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 5 0.0001
984 INTENTIONAL OVERDOSE 9 0.0001
985 SUICIDE ATTEMPT 8 0.0001
986 NO ADVERSE EVENT 22 0.0001
987 DEVICE DIFFICULT TO USE 8 0.0001
988 DRUG DEPENDENCE 18 0.0001
989 DRUG ABUSE 5 0.0001